What is SynBioBeta?
SynBioBeta operates as a global community dedicated to advancing synthetic biology. It serves as a nexus for biological engineers, entrepreneurs, investors, and innovators, fostering collaboration and the engineering of biology. The company's offerings include industry information, strategic insights, and crucial networking opportunities, primarily through organizing prominent events like the SynBioBeta 2026 conference. Its target audience comprises professionals and organizations within biotechnology, healthcare, and related fields aiming to enhance their expertise and connections in synthetic biology.
How much funding has SynBioBeta raised?
SynBioBeta has raised a total of $120K across 1 funding round:
Debt
$120K
Debt (2021): $120K with participation from PPP
Key Investors in SynBioBeta
PPP
Public-Private Partnership
What's next for SynBioBeta?
The substantial capital infusion, indicated by the $120K and $120K, positions SynBioBeta for accelerated growth and expanded influence within the synthetic biology ecosystem. This strategic backing is expected to fuel further development of its community-building initiatives, event programming, and information dissemination services. The company is poised to solidify its role as a key facilitator for innovation and investment in the rapidly evolving field of synthetic biology, potentially exploring new avenues for engagement and market penetration.
See full SynBioBeta company page
